Evidence map›Paper›PMID 21739670›Full record

ReviewNature immunology2011

Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells.

Jonathan Sprent, Charles D Surh

Abstract readReview
In one paragraph

Review in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 305 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed, 1 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

305 citing papers in PubMed, 1 synthesis or guideline pooled it, 471 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. Article
  6. Review
  7. mScience advances · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Jonathan SprentGarvan Institute of Medical Research, Sydney, New South Wales, Australia. j.sprent@garvan.org.au
Charles D Surh
Garvan Institute of Medical Research · AUPohang University of Science and Technology · KR

Funding

Modulation of T Cell Responses with CytokinesR01AI075164 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SURH, CHARLES D. · 2009 to 2012
$1.9M
T Cell Regulation of Commensal Antigen PresentationR21AI090610 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SURH, CHARLES D. · 2010 to 2011
$520k
NIAID NIH HHS R01 AI075164NIAID NIH HHS R21 AI090610
6 · The paper itself

Abstract

Weak T cell antigen receptor (TCR) signals from contact with self ligands act in synergy with antiapoptotic signals induced by interleukin 7 (IL-7) to promote the survival of naive T cells in a resting state. The amount of background TCR signaling in naive T cells is set by post-thymic TCR tuning and operates at an intensity just below that required to induce entry into the cell cycle. Costimulation from higher concentrations of IL-7 and other common γ-chain cytokines can induce T cells to undergo homeostatic proliferation and conversion into cells with a memory phenotype; many of these memory phenotype cells may be the progeny of cells responding to self antigens. The molecular mechanisms that control the conversion of naive resting T cells into memory-phenotype cells TCR-dependent in normal animals are beginning to be understood.

Indexed as

AnimalsCell SurvivalHomeostasisHumansImmunologic MemoryInterleukin-7Models, ImmunologicalReceptors, Antigen, T-CellSignal TransductionT-LymphocytesInterleukin-7Receptors, Antigen, T-Cell

Identifiers

PMID21739670
PMCPMC3434123
OpenAlexW2058158581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.